The role will be responsible for the development, implementation, and execution of tailored sales strategies to leverage Crown Bioscience's business opportunities in the area of translational science, specifically Oncology.
This is fully remote position for those based on east coast.
Responsibilities:
•Develop and implement strategic sales plans (short term and long term) to achieve corporate goals in the assigned market;The role will be responsible for the development, implementation, and execution of tailored sales strategies to leverage Crown Bioscience's business opportunities in the area of translational science, specifically Oncology
•Identify and analyze business opportunity, and formulate plans to capture the opportunity and deal with problems;
•Contact prospective customer/partner companies to further explore business opportunities and manage negotiations;
•Develop and maintain key business relationships across a broad sphere of influence, both internally and externally.
•Logistics management in daily order.
Minimum Requirements:
•Bachelor Degree in Molecular and Cell Biology or related life science field
•Drug discovery experience selling to biotech – at least 4-5 years of experience
•Relevant business development experience (Biotech, CRO) is required
•Masterful selling skills that result in strong, trusting customer relationships
•Masterful negotiation experience with preferred background knowledge
•Flexibility spending up to 40% travel after pandemic when needed
Preferred Requirements:
•Have strong background in oncology and in vivo pharmacology highly desired.
For Director, Business Development, salary range is $130,000-155,000
This salary (or salary range) is merely an estimate and may vary based on an applicant’s skills and prior relevant experience.
Crown Bioscience is committed to a diverse and inclusive workplace. Crown Bioscience is an equal opportunity employer and does not discriminate based on race, national origin, gender, gender identity, sexual orientation, protected veteran status, disability, age, or other legally protected status.
Crown Bioscience, a JSR Life Sciences company, is a global contract research organization (CRO) dedicated to accelerating drug discovery and development in oncology and immuno-oncology. We partner with biotech and pharmaceutical companies to provide innovative, tailored solutions spanning preclinical research, translational platforms, and clinical trial support.
With the world’s largest commercially available patient-derived xenograft (PDX) collection and approximately 1,000 tumor organoid models powered by Hubrecht Organoid Technology, we offer unparalleled insights across 35 cancer indications.
Our expertise spans in vivo, in vitro, ex vivo, and in silico methods, complemented by advanced laboratory services that span the entire drug development continuum. Additionally, our extensive biobank of liquid and human biospecimens, complete with clinical histories, enhances oncology research capabilities.
Operating from 11 state-of-the-art facilities across the US, Europe, and APAC, our laboratories meet the highest industry standards, including accreditation by the College of American Pathologists (CAP) and the International Organization for Standardization (ISO).
To learn more, visit www.crownbio.com.
